3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Brain Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Polycythemia Vera
4
Glioblastoma
4
Meningioma
3
Leukemia, Myeloid, Acute
3
Pharyngeal Neoplasms
2
Paranasal Sinus Neoplasms
2
Neoplasms
2
Laryngeal Neoplasms
2
Head and Neck Neoplasms
2
Gliosarcoma
2
Thrombocytosis
1
Thrombocythemia, Essential
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Papillomavirus Infections
1
Oropharyngeal Neoplasms
1
Nose Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Hodgkin Disease
1
Glioma
1
Epstein-Barr Virus Infections
1
Carcinoma, Squamous Cell
1
Carcinoma
1
Astrocytoma
1
Adenocarcinoma
1
Interventions
Temozolomide
14
Bevacizumab
11
Erlotinib Hydrochloride
5
Radiotherapy
4
Carboplatin
4
Magnetic Resonance Spectroscopy
3
Irinotecan
3
Immunoglobulin G
3
Disulfides
3
temsirolimus
2
poly ICLC
2
palbociclib
2
etoposide phosphate
2
antineoplaston AS 2-1
2
antineoplaston A10
2
Vincristine
2
Sunitinib
2
Sirolimus
2
Everolimus
2
Dasatinib
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
veliparib
1
varlilumab
1
vandetanib
1
trebananib
1
trametinib
1
terameprocol
1
tandutinib
1
selinexor
1
romidepsin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Oligodendroglioma
×
Hydroxyurea
×
Clear all
No trials found.